Purchase Order 75N93024P01092
Award Date
9/23/24
Potential Completion Date
9/22/25
Potential Value
$210K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Creative Biolabs Inc.
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
The National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, awarded a $18,500 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for laboratory testing, fusion, and cloning services. The contract has an ultimate completion date of November 30, 2024 and does not have a set-aside designation. This award is part of a larger $100 million Blanket Purchase Agreement (BPA)...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $28,590.00 firm fixed-price purchase order contract to Abveris, Inc. to provide hybridoma generation cell panel services using mice. This sole-source contract was issued under the authority of 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1, as no other source could provide the required proprietary Abveris hyperimmune DiversimAb mice and associated services. The contract...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Creative Dynamics, Inc. (DBA Creative Biolabs) for the acquisition of recombinant human anti-influenza A virus (IAV) antibody in a 5mg quantity. The contract has a ceiling value of $7,960.00 and was awarded on October 31, 2017, with a planned completion date of January 31, 2018. This contract does not...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $10,580.00 firm fixed-price purchase order to Lofstrand Labs LTD, a for-profit limited liability company, for antibody production and purification services. The contract does not have a set-aside designation and has an ultimate completion date of May 26, 2017. Lofstrand Labs LTD is the prime contractor, and no subcontractors are mentioned. The award is not associated with a larger contract vehicle...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
<p>The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $45,900.00 firm fixed price purchase order to Ehime University, a non-profit organization, for antibodies production services. This contract, with a completion date of February 1, 2014, was not set aside for any specific business type. No additional context about NIAID's programs was provided.</p>
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $70,395.88 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the delivery of antibody production and gene synthesis services, including mammalian expression, cloning, and plasmid preparation, to support NIAID's biomedical research and public health initiatives....
The National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $59,541 firm fixed price purchase order to Genscript USA Inc. to provide customized antibody synthesis, expression, purification, and plasmid preparations in support of the Laboratory of Malaria Immunology and Vaccinology's (LMIV) malaria vaccine research. Per the original solicitation, LMIV requires custom monoclonal antibodies that can label and sort immune cell subsets in its colony...